IFNL4 and prostate cancer: Although the OR point estimate for the association of HHV-8 with prostate cancer in men with IFNL4-ΔG was higher in EA than AA men (2.59 vs. 1.96), the 95% CIs largely overlapped, suggesting comparable risks.